Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.

MLA

Abhyankar, Mayuresh M., et al. “Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.” Frontiers in Immunology, vol. 12, June 2021, p. 683157. EBSCOhost, https://doi.org/10.3389/fimmu.2021.683157.

APA

Abhyankar, M. M., Orr, M. T., Kinsey, R., Sivananthan, S., Nafziger, A. J., Oakland, D. N., Young, M. K., Farr, L., Uddin, M. J., Leslie, J. L., Burgess, S. L., Liang, H., De Lima, I., Larson, E., Guderian, J. A., Lin, S., Kahn, A., Ghosh, P., Reed, S., … Fox, C. B. (2021). Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy. Frontiers in Immunology, 12, 683157. https://doi.org/10.3389/fimmu.2021.683157

Chicago

Abhyankar, Mayuresh M, Mark T Orr, Robert Kinsey, Sandra Sivananthan, Andrew J Nafziger, David N Oakland, Mary K Young, et al. 2021. “Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.” Frontiers in Immunology 12 (June): 683157. doi:10.3389/fimmu.2021.683157.